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Abstract: The COVID-19 pandemic has caused hundreds of thousands of
deaths, millions of infections worldwide, and the loss of trillions of dollars
for many large economies. It poses a grave threat to the human population
with an excessive number of patients constituting an unprecedented challenge
with which health systems have to cope. Researchers from many domains
have devised diverse approaches for the timely diagnosis of COVID-19 to
facilitate medical responses. In the same vein, a wide variety of research studies
have investigated underlying medical conditions for indicators suggesting the
severity and mortality of, and role of age groups and gender on, the probability
of COVID-19 infection. This study aimed to review, analyze, and critically
appraise published works that report on various factors to explain their rela-
tionship with COVID-19. Such studies span a wide range, including descriptive
analyses, ratio analyses, cohort, prospective and retrospective studies. Vari-
ous studies that describe indicators to determine the probability of infection
among the general population, as well as the risk factors associated with severe
illness and mortality, are critically analyzed and these  ndings are discussed
in detail. A comprehensive analysis was conducted on research studies that
investigated the perceived differences in vulnerability of different age groups
and genders to severe outcomes of COVID-19. Studies incorporating impor-
tant demographic, health, and socioeconomic characteristics are highlighted
to emphasize their importance. Predominantly, the lack of an appropriated
dataset that contains demographic, personal health, and socioeconomic infor-
mation implicates the ef cacy and ef ciency of the discussed methods. Results
are overstated on the part of both exclusion of quarantined and patients with
This work is licensed under a Creative Commons Attribution 4.0 International License,
which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited.
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mild symptoms and inclusion of the data from hospitals where the majority
of the cases are potentially ill.
Keywords: COVID-19; age & gender vulnerability for COVID-19; machine
learning-based prognosis; COVID-19 vulnerability; psychological factors;
prediction of COVID-19
1 Introduction
The last two decades have witnessed several pandemics that challenged the capacity of our
health system and destroyed the so-called claim of medical advancement. Pandemics such as
severe acute respiratory syndrome (SARS), Ebola, Middle East respiratory syndrome (MERS)
caused thousands of deaths and altered human living conditions and daily activities. The term
“pandemic” refers to the outbreak of an infectious disease that endangers millions of lives
distributed over large geographical areas while epidemics are restricted to a speci c location,
city, or country [1]. In December 2019, another severe disease, called coronavirus disease 2019
(COVID-19), emerged in Wuhan, Hubei Province, China, and began to spread rapidly. Within
the next few weeks, it became a global outbreak and was declared a pandemic by the World
Health Organization (WHO). COVID-19 is caused by SARS Coronavirus 2 (SARS-CoV-2) and
attacks the respiratory system, leading to high mortality in critically ill patients and people with
preexisting respiratory problems [2]. By the end of September 2020, 33.72 million people had been
diagnosed with COVID-19, and worldwide 1.009 million were dead [3]. COVID-19 has caused the
loss of trillions of dollars and widespread unemployment in many large economies. For example,
the US had only 1% of the population receiving unemployment bene ts before COVID-19 that
increased to 18% by early May 2020 [4]. Besides  nancial upheaval and social tumult, COVID-19
is reshaping the working and living conditions and the patterns of our social interactions.
The medical community has responded promptly to COVID-19, and a broad range of tech-
niques in multifarious domains such as medical prognosis, diagnosis, prevention, and treatment
have been proposed. Such studies have helped diagnose COVID-19 patients readily and led to the
clinical trials of many potential medicines for Ebola and SARS. The research community inves-
tigated many machine learning and deep learning models to help medical professionals diagnose
COVID-19 patients to tackle the burden of the fast-paced spread of COVID-19. The research
covers many aspects of COVID-19 patients such as clinical symptoms, the impact of age group
on mortality, and the use of imaging technology to identify potential COVID-19 patients, and are
broadly categorized into nine groups as shown in Fig. 1.
Several reviews of the research in the aforementioned categories have been available. For
example, [5] provides an overview of the machine and deep learning approaches to the diagnosis
of COVID-19. It critically analyzes arti cial intelligence algorithms used for the prediction and
diagnosis of COVID-19 patients. Nucleic acid testing and protein testing are laboratory tests
for COVID-19 patients, and many kits have been designed for this purpose [6]. Such tech-
niques require random-access, integrated devices with scalable capacities to facilitate the rapid
diagnosis of COVID-19 patients [7]. Laboratory techniques require specialized equipment and
are time-consuming. Conversely, computed tomography (CT), and X-ray (or radiography) images
are utilized to assist and facilitate medical professionals for the initial and rapid prediction of
COVID-19 patients. Consequently, prognostic and diagnostic studies are predominantly based on
imaging techniques. Therefore, many review papers cover imaging-based machine and deep learn-
ing approaches presented to diagnose COVID-19 patients. For example, [8] presents an exploration
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of the role of imaging in detecting COVID-19 patients and discovering the symptoms of the
disease from images. These characteristics are revealed using CT, X-ray, and ultrasound images
of COVID-19 patients. Such characteristics/symptoms are discussed during different phases of
the disease, that is, diagnosis, treatment and follow-up. Reference [9] presents a critical appraisal
of various diagnostic and prognostic models presented for COVID-19. The models are discussed
regarding the sample size, number of predictors, type of adopted validation, and risk of bias in
each model. Similarly, [10,11] detail investigations of the approaches based on chest CT, X-ray,
and ultrasound images and outlined the important  ndings identi ed by these approaches. The
differential diagnosis of COVID-19 patients is also characterized, along with the complications of
COVID-19. Despite the elaborate discussions in the above-cited works, the majority of the review
papers focus mainly on the diagnostic models based on imaging technology. Thus, they neglect
many important categories such as statistical models to predict the probable number of patients
in a city or country, prediction of mortality or severity, and how gender is related to COVID-19
vulnerability? Tab. 1 shows a comparison of the topics covered by the research works discussed
and highlights the contribution of the current study.
Figure 1: Classi cation of COVID-19 research works
This study mainly focused on models that predict mortality or the severity of illness among
COVID-19 patients, statistical models for COVID-19, and how gender groups are affected in the
wake of the pandemic. Additionally, the impact of preexisting medical conditions, such as dia-
betes, hypertension, and heart disease, and the exposure of COVID-19 patients to other diseases
are analyzed. Because many review papers have covered machine and deep learning research on
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imaging technology, this paper discusses only the most recent works in this regard. In summary,
this study makes the following contributions:
• Contrary to previous studies that focused on studying diagnosis and prognosis models, the
current study analyzed the models proposed to predict the number of patients in a locality,
county, or country.
• Machine learning and deep learning approaches used to predict the severity of illness or
probability of death are discussed and analyzed comprehensively.
• Studies that investigated the vulnerability to COVID-19 by gender are discussed along with
the outcomes.
• Studies suggesting the risk of COVID-19 leading to various psychological and physiological
disorders are given special consideration in the current study.
• The risk of death or complicated medical conditions associated with preexisting diseases,
such as heart problems, diabetes, and hypertension, is discussed.
The rest of the paper is organized as follows. Section 2 discusses the models that predict
the number of patients for various cities and countries. Extant studies concerning the exposure
and vulnerability of COVID-19 patients to other diseases are discussed in Section 3. Section 4
describes research that analyzes the complications affecting COVID-19 patients with preexisting
medical conditions. In contrast, Section 5 analyzes research that, by gender, highlights the impact
of COVID-19 on patients. Research that emphasizes the mortality or severity prediction of
COVID-19 is reviewed in Section 6. Future research directions are discussed in Section 7, and the
conclusion is presented in Section 8.
Table 1: Summary of the contributions of the current study
Features [8] [9] [10,11] [5] Current survey
Image-based diagnosis and prognosis models Yes Yes Yes Yes Yes
Image  ndings (CT, X-ray) Yes No Yes No No
DL & ML classi cation No Yes No Yes Yes
Critical analysis of prediction models No Yes No Yes Yes
Statistical models for COVID-19 prediction No No No No Yes
Prediction of COVID-19 patients and fatality No No No No Yes
Gender-based COVID-19 studies No No No No Yes
Clinical  ndings of drug treatments No No No No Yes
Risk analysis of various diseases due to COVID-19 No No No No Yes
2 Prediction Methodologies for Number of Patients of COVID-19
Owing to the rapid and widespread outbreak of the COVID-19, governments face dif culty
in devising appropriate and prompt policies to adopt preventive measures. The derivation of
models with the capability to predict the probable number of patients in a particular area provides
advantages for planning appropriate policies to  ght the disease. For this reason, researchers have
modeled diverse algorithms that can predict high-risk areas and the number of people who are
likely to be affected by the pandemic.
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2.1 Machine and Deep Learning Models
A mathematical model is presented in [12] that can predict the number of patients in a
speci c country given the previous number of patients. The logistic model is modi ed to make
it integrable and produce results with the measured data from different countries. The data
from three countries—China, Austria, and France—are used to evaluate the performance of the
proposed model. Various generalizations of the model have been proposed to deal with areas
with various space distributions and low- and high-mortality cases. The model cannot incorporate
important parameters such as quarantine and large distributions of COVID-19 patients. Similarly,
it cannot be applied to each country. The data are used from Austria and China, where the
infected population’s spatial distribution is most localized and does not apply to countries such
as the United States and India where the cases are highly scattered in each state.
Accurate forecasting of the outbreak has signi cant importance in mitigating the impact of
the disease as it enables the governments to plan beforehand. Reference [13] presents an analysis
of the capability of various time-series models for outbreak prediction in various countries.
Six models were tested, namely, autoregressive-integrated moving-average (ARIMA) model [14],
Holt-Winters additive (HWA) model [15], trigonometric Box-Cox autoregressive-moving-average
(ARMA) trend (TBAT) model [16], Facebook’s Prophet [17], DeepAR [18,19], and neural basis
expansion analysis for interpretable time series (N-BEATS) [20]. The study revealed that a one-
size- ts-all approach does not apply to COVID-19 case prediction. However, statistical methods
such as ARMA and TBAT are superior to their counterpart deep learning approaches such as
DeepAR and N-BEATS to predict patient numbers seven days ahead. The performance analysis
is based on the root mean square error (RMSE) and Friedman’s test to rank the algorithms.
Despite the signi cant performance superiority of TBAT over Prophet, DeepAR, and N-BEATS,
the inter-country performance cannot be explained because of climatic, population, testing, disease
duration, and other similar characteristics related to the spread prevention of COVID-19.
A hybrid machine learning approach was proposed in [21] to predict the number of COVID-
19 patients in Hungary. The proposed model is based on an adaptive network-based fuzzy
inference system (ANFIS) and a multilayered perceptron-imperialist competitive algorithm (MLP-
ICA). The training was performed on the data acquired from 4 March to 19 April, while the
testing was performed on the data acquired from 20 April to 28 April to predict the infected
population and mortality rate. Three member functions, namely, triangular, trapezoidal, and
Gaussian functions, are analyzed for their performance with ANFIS. Accuracy is established
through the determination coef cient, mean absolute percentage error (MAPE), and RMSE. MLP-
ICA is evaluated based on the number of neurons for the generation of empires. The results
indicate that the machine learning models show superior performance compared to susceptible-
infected-recovered (SIR)-based models to predict the infected patient numbers and mortality for
COVID-19. However, the proposed approach is tested on Hungary’s data, and it is not clear
whether it is adequate for different population densities and sizes.
A Gauss model was studied in [22] to predict the number of active cases and deaths per
day for 25 countries. The quadratic function is found to be suitable for predicting fatalities for
each country separately. The model can predict mortality per country, with additional aspects
of the peak number of deaths per day, date of peak deaths, and the period during which the
deaths occur. The adoption of the bell-shaped Gauss model demonstrates such models’ potential
to predict COVID-19 cases; however, they may not be appropriate for all countries, as the results
show large errors in the  tted curves. Asymptomatic patients also make it dif cult to estimate the
true case fatality ratio (CFR) for the COVID-19 pandemic. Reference [23] presents an investigation
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of a crude CFR model to predict COVID-19 cases and fatalities in Korea using the Monte Carlo
Markov-Chain method with the Bayesian framework. It reports that the CFR for Korea is higher
than that of China. Early CFR values were low, indicating a delay in reporting con rmed cases or
increasing ascertainment bias. In the initial phase of an epidemic, the true CFR is underestimated
in current and previous studies.
Reference [24] presents a deterministic and stochastic modeling approach to predict Kuwait’s
con rmed COVID-19 cases. Owing to the unavailability of a detailed dataset, which is necessary
for ABMs (agent-based models), the SIR approach is followed. The SIR approach and logistic
regression are adopted to predict the epidemic size and its probable ending phase. Changes in the
susceptible patients numbers are modeled using the individual contact model (ICM) model with
various reproduction number values. Reference [25] presents the use of a logistic model to predict
the number of infected people in India. For this purpose, the logistic-growth curve model is used
for active cases, while SIR models are used for the maximum number of active cases and peak
time. Additionally, the impact of lockdown and other similar restrictions is taken into account for
the time interrupted regression (TIR) model. The predictions follow the patterns for short-term
cases. However, to predict long-term cases and incorporate additional government interventions,
the approach needs to be remodeled. An exploratory time-series analysis was adopted in [26]
for predicting COVID-19 cases in Greece. A regression spline model was adopted to analyze the
evolution of COVID-19 cases by  rst determining the spline knot vector using a complex-network-
based approach. The results demonstrate that the complex-network spline demonstrates superior
performance compared to the cubic and regression models. The approach was tested on Greece’s
data only and may require remodeling or parameter tuning for other countries. Other parameters,
such as isolation, quarantine, and social distancing, are not incorporated in this study.
Incorporating the government’s interventions in a prediction model may potentially make
it highly useful for accurate predictions. For example, [27] considered intervention measures to
analyze the evolution of COVID-19 in European countries. The data from Spain, Italy, UK,
Germany, and France were used to  t the model for predicting infections and the infections-
to-deaths rates. Analysis con rms other studies’  ndings that government restrictions, including
social distancing, quarantine, and isolation, can potentially slow down the spread of infection.
However, the model using the probability distributions based on the historical data of infections
to the probability distributions based on the historical data of China’s infection-to-death ratios.
Changing such data for other countries will change the probability distributions and output of
the model. Additionally, the R value in the regression model varies over time and takes different
values for each country. The R value was assumed to be constant in this study.
2.2 Susceptible-Infected-Recovered Models
A SIR model was used in [28] to  t the data related to COVID-19 patients for New Jersey
(NJ) and New York (NY) states in the US. The presented model was a classical SIR model with
a non-autonomous approach in which the rate of susceptible people and deaths are adjusted to
 t the available data. The following two assumptions were made to the model for data  tting:
many infected people are not tested positive, and lockdown policies reduce the transmission and
infection rates. The model predicts disease waves in NY followed by NJ and the exponential
increase, peak, and decrease of the pandemic. A different approach was adopted in [29], wherein
the empirical data from South Korea and Italy were used to forecast long-run cases in Utah
State, USA. A log-logistic model was used to align the start of the pandemic in Utah. The
model involves the following four parameters: The initial infected population size (c),  nal infected
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population size (d), inection point of the logistic curve (e), and scaling factor (b) representing
the slope parameter. The model indicated a pandemic level similar to that of South Korea. The
model can make short-run predictions with fair accuracy, while the long-run forecast is neither
robust nor accurate
COVID-19 cases were predicted for Pakistan using a model called the exponential inverse
exponential exponential (EMIEE), which is based on the exponential M (EM) family of contin-
uous distributions [30]. Model parameters were estimated using the maximum likelihood method.
The proposed model is used to estimate the number of infected people in Pakistan and peak time,
and to compare the number of cases with other countries. Performance analysis with other models
showed promising results. Two models were adopted in [31] to realize a real-time prediction of the
COVID-19 outbreak for Saudi Arabia based on empirical data from 2 March to 15 May 2020.
The logistic-growth and SIR models were used to predict the number of infected people across the
country. The modeling timescale was assumed to be short with no vital dynamics, and a constant
host population size was considered for the SIR model. The infection was predicted concerning
the peak, transition, and decrease phases. The logistic model showed better performance than
the SIR model. Similarly, a SIR model was leveraged to predict the COVID-19 peak duration
in Malaysia [32]. Initially, a genetic algorithm was used to estimate the infection rate, and the
adaptive neuro-fuzzy inference system model provided an estimate of short-term infected cases.
The impact of government constraints was also considered to delay the peak time of the epidemic.
Additionally, the prediction showed that intervention can reduce the infection rate, and longer
intervention periods would reduce the epidemic’s scale during the peak.
The epidemic peak for COVID-19 was predicted for Japan by [33] using the susceptible-
exposed-infectious-removed (SEIR) compartmental model. The reproduction number was esti-
mated with the help of the lease-square-based method with Poisson noise. The impact of
government intervention was assumed to slow down the infection rate. The peak was predicted to
be in July. Research indicates that interventions over a longer period positively reduce the scale
of the  nal epidemic. Additionally, the epidemic size would be less likely to be impacted by the
actual infective population. The number of patients was predicted in [34] using a rolling gray
Verhulst model. Six models were used on 7, 8, and 9-day data for predicting con rmed cases of
COVID-19. The MAPE was used to evaluate the performances of the models during the training
phase. Only the data from 20 January to 20 February 2020, for COVID patients from China, were
used for the models; therefore, the results cannot be generalized. Many important parameters,
such as imposed restrictions, lockdown, and environmental conditions, were not considered.
Reference [35] presents the use of a multiple ensemble neural network model with fuzzy
response aggregation to predict COVID-19 cases in Mexico. Multiple neural networks were trained
for prediction, and the  nal output was generated using fuzzy logic, which considers uncertainty.
Short-term data were used for prediction with an increasing trend, making it simple but unsuitable
for data with multiple trends. Similarly, a deep learning approach was used in [36] to predict
the trend of COVID-19. Various long short-term memory (LSTM) adaptations such as vanilla,
stacked, multilayer, and bidirectional LSTM were analyzed for their ef cacy in predicting the
number of infected people. Correlation analysis was also performed considering factors such as
temperature, rainfall, sunshine, population, infected cases, death, and population density. The
study concluded that COVID-19 has no dependence on the weather, such as sunshine, temperature,
precipitation, while social distancing is vital to reduce the spread.
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2.3 Use of Social Media Search Index
Contrary to traditional methods that utilize empirical time-series data for prediction, [37]
predicted suspected cases from the social media search indexes (SMSIs) for various symptoms of
COVID-19, such as dry cough, fever, chest distress, and pneumonia. Lagged series were used to
predict suspected cases. Subset selection, forward selection, lasso regression, ridge regression, and
elastic net are used as coef cients to avoid over tting. The study demonstrated the signi cance
of using SMSI data by indicating that suspected cases can be detected 6–9 days earlier. While
using SMSI, the correlation with suspected case numbers differs for each day considered, showing
that although SMSI can sense an outbreak, it is not a tool to predict con rmed COVID-19
cases conclusively. Reference [38] presents a space and time correlation approach to predict the
community outbreak for COVID-19 in the USA. Proxy datasets were generated from publicly
available news articles. Then, spatial analysis can provide insights into space–time patterns of
COVID-19. The analysis  ndings indicate the need for strict social distancing during the disease’s
initial spread to slow down its impact.
2.4 Critical Analysis of Methods
The use of forecasting models to predict the number of COVID-19 infected people can be
grouped into the following three categories: Machine learning models, SIR models, and deep
learning models. Machine learning models include both classical machine learning algorithms and
other models such as logistic, correlation, and Verhulst models. Although a subset of machine
learning, deep learning models are categorized according to their operational processes, such as
feature extraction, parameter tuning, and processing capabilities.
SIR models are epidemiological algorithms used to predict the number of infections based
on suspected, infected, and recovered patients’ empirical data. A challenge to devising a model
for long-term prediction is the lack of essential data to analyze its performance. Additionally,
the uncertainty in data restricts the higher accuracy of epidemiological models. Machine learning
models show promising results in the research works discussed when experimented on with limited
data. The data are limited in terms of locality or time. Most studies analyze the models’ perfor-
mance on data from a single country and a limited time. The limitation of such models is that
each would perform differently because of the underlying assumptions. Similarly, differences in
population density, environmental conditions, health system capacity, government control over the
people to enforce interventions, and socioeconomic conditions would affect a model’s results. Deep
learning models are data-intensive and can behave differently because of the data provided for
training. Additionally, the prediction and analysis using deep learning-based models are conducted
under simple or ideal conditions and do not consider the complex scenarios with a large number
of variables that pertain in real conditions. This can adversely affect the prediction of such models.
In addition, deep learning models require large amounts of data to support parametrization.
Lack of suf cient data may signi cantly vary the prediction results. In addition, such models
require extensive hyperparameter tuning related to the number of hidden layers used in a model
that increase their complexity. Currently, there is uncertainty about the transparency of various
governments in reporting the actual number of COVID-19 patients. It would be possible to
miss a signi cant number of con rmed cases that may inuence a given model’s accuracy. One
advantage of a model is the distribution of the number of infected cases given a similar feature
set, such as population, climate, health system, and sanitary conditions, which are missing in the
proposed models.
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Tab. 2 presents a summary of the methods used to predict the number of patients with
COVID-19. Three types of models are used to predict the total number of COVID-19 patients
for various cities, countries, and continents, namely, machine learning models, SIR models, and
deep learning models. A major challenge for prediction with such models is the availability of a
suitable dataset that carries the patients’ geographical, medical, and personal details. Many issues
related to data uncertainty, such as incomplete records, an increased or decreased number of
patients reported, and nature of symptoms (symptomatic/asymptomatic), restrict the utilization of
a model’s full potential. For example, without the aforementioned data, the SIR model cannot
perform a long-run prediction. Although machine and deep learning approaches show promising
results for accurate predictions, in the same vein, their performance is not generalized. Owing to
the uncertainty in data used for training and testing, the performance of such models may vary
signi cantly. The data is often limited by time and space, and changes in the data may cause
very different results. Typically, many important factors are not considered, such as environmental
conditions, population density, health and medical conditions of a society, government interrup-
tions, and socioeconomic conditions, which have a direct or indirect impact on the spread of the
pandemic. The lack of transparency of various governments in reporting the number of infected
people is also an issue in estimating the number of infections with adequate accuracy.
Table 2: Summary and critique of the research that predicts the number of COVID-19 patients
Reference Method used Scope Advantages Shortcomings
[26] Regression spline Narrow Remodeling or parameter
tuning is possible for other
countries.
Isolation, quarantine, and







(reproduction) for the model
is taken as constant, disease




Narrow Daily uxes between two
states are considered to
predict infected cases.
Assumptions such as a large
number of infected people
not testing positive and
lockdown reduces infection
rates are not appropriate.
[29] Log-logistic
model
Narrow Use of case studies for a
prediction about intact areas
of infection.
Long-term predictions are





Narrow Daily, as well as, monthly








Narrow A simple model with few
parameters, parameters are
calculated using historic data.
No dynamics are considered,
the host population is kept
constant.
(Continued)
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Table 2: Continued
Reference Method used Scope Advantages Shortcomings
[32] Genetic,
neuro-fuzzy
Narrow Intervention measures are
taken into account for
modeling.
Model is used with a smaller
dataset, long- term
forecasting is not done.
[33] SEIR Narrow Impact of government
intervention is considered,
short & long-term impact of
lockdown is analyzed.
Uncertainty due to social
and natural changes like
distancing, infection
scenarios, change in
lockdown is not incorporated
[34] Grey Verhulst
models
Narrow Robustness, accuracy over
short-term prediction.
Results are not generalized




Narrow Simple, easy to implement,
robust for short-term data.
The long-term prediction is




Wide The impact of weather is
considered, social distancing
is taken into account.
Only the uni-variate trend of
time-series data is considered;
age, sex, and health factors
are not associated with data
analysis.
[37] Lagged series, the
social media
search index
Narrow Use of social media to
predict COVID-19 cases with
search indices, early detection
of infected cases.
Prediction is not conclusive
and may be superuous.
Baidu is not known in every
country, no COVID-19
related factors are analyzed.
[38] Geospatial
analysis
Narrow Geospatial analysis is
performed to analyze the
space—time pattern of
disease spread and the role
of social distancing is
well-studied.
Infection clustering is not
studied, non-stationary
effects are not considered for
the research.
3 Exposure of COVID-19 Patients to Other Diseases
Viral infections, such as those by rhinovirus, respiratory syncytial virus, inuenza virus,
human parainuenza virus, and metapneumovirus, are regarded as triggers for many other dis-
eases [39–41]. In light of such  ndings, it would be highly appropriate to investigate the impact
of the COVID-19 virus in exposing infected people to other diseases. Consequently, numer-
ous studies that analyze COVID-19 patients for its impact, both positive and negative, on the
vulnerability/resistance of the patients to other diseases.
3.1 Asthma
The authors performed a Mann–Whitney U and chi-square test in [42] to study the impact
of COVID-19 on asthma in a population of 376 con rmed patients. In contrast, the effect of
medications used to treat asthma was analyzed in COVID-19 patients. The study indicated that
asthma prevalence in patients with COVID-19 is low and not associated with asthma exacerbation.
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It was also suggested, as did other studies [43,44], that inhaled corticosteroids with or without
bronchodilators can inhibit coronavirus replication.
3.2 Cardiac Complications
Possible cardiac complications were studied in [45] using magnetic resonance imaging (MRI)
images from 26 recovered COVID-19 patients who reported cardiac symptoms. Tests were
performed using various models such as Shapiro–Wilk, Student’s t-test, analysis of variance
(ANOVA), Mann–Whitney U test, and Kruskal–Wallis test. Various symptoms were found in
recovered patients, such as abnormal MRI in 58% of patients, myocardial edema in 54%, and
late gadolinium enhancement (LGE) in 31% of patients. Cardiac involvement was found in many
of the examined patients with MRI manifestations involving myocardial edema,  brosis, and
impaired right ventricular (RV) function. Another study [46] investigated the correlation between
cardiovascular disease (CVD) and COVID-19 and suggested that the patients have a prevalence of
CVD. This prevalence is signi cantly higher in critically ill patients than in those with relatively
mild disease.
3.3 Mental Disorders
Information on mental health problems in adults resulting from the COVID-19 pandemic
was examined using a survey [47]. Studies indicate that the pandemic’s perceived negative impact
has a signi cant effect on mental health problems, including sleeplessness, depression, and post-
traumatic symptoms in the general population. Cognitive and prosocial coping behaviors can
help relieve such problems; therefore, cognitive-behavioral treatments should be engineered. The
authors performed a study to examine COVID-19 related stress among people in Iran [48]. The
survey contains 54 items about demographic characteristics, past medical history, stress levels, and
awareness of COVID-19 symptoms. The mean age of the 3787 participants was 34.9 years, 66.6%
were without chronic disease, and 67.4% were female. The stress score was weighted between 1
and 5, from very low to very high, and the average stress score among the participants was 3.33.
A higher stress score is associated with females aged between 30 and 39 years with chronic disease.
A structured questionnaire was used in [49] to assess the mental health of people in Hong
Kong. The questionnaire was completed by 500 randomly recruited participants. The question-
naire contained structured questions about health, anxiety disorder level, rating of change scale,
and COVID-19 related items. Multiple logistic regression indicated that 19% and 14% of the
participants had high depression and anxiety, respectively, while an additional 25.4% faced mental
health deterioration. Poor mental health problems are caused by the fear of getting infected with
COVID-19, unavailability of enough masks, and inability to work from home.
3.4 Sleep Disorder, Hypertension, Stress, and Psychological Problems
In [50], the authors included stress, physical activity, alcohol intake, and cigarette smoking
in addition to depression, anxiety, and sleep in an online survey conducted for Australians. The
survey results, completed by 1491 adults, show that COVID-19 affected people’s lives negatively
by 48.9% for physical activity, 40.7% for a sleep disorder, 26.6% for alcohol use, and 6.9% for
smoking. Such negative changes are highly associated with females and single people with low
incomes aged between and 18–45 years.
Similarly, the reference [51] presents a study on COVID-19 related psychological responses of
health workers and physicians. The online survey covered three aspects, namely, sociodemographic
(age, gender, marital status, etc.), working conditions, and the Depression Anxiety and Stress scale
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(DAS)-21. The analysis was performed using Student’s t-test, ANOVA test, and multiple linear
regression analyses on the data collected from 442 participants. Depression, anxiety, and stress
were found in 64.7%, 51.6%, and 41.2% of participants, respectively. A high score is associated
with being female, young, single, having low work experience, or being a frontline worker, while
this score is relatively low for workers having children. A higher score in DAS-21 is caused by
increased working hours, a higher number of COVID-19 patients, lower-level peer support, lower
logistic support, and feelings of lower competence.
In a similar study [52], the authors analyzed the impact of lockdown on mental health and
sleep disturbance in Italy. The questionnaire contained sociodemographic characteristics, people
behaviors and healthcare, and patient health questionnaire-2 and generalized anxiety disorder-2.
Sleep disorder was analyzed using the insomnia severity index with a population size of 1515.
Group differences were de ned using the chi-square and Mann–Whitney U tests. Univariable and
multivariable logistic regression was used to determine the inuence of individual variables. Results
showed that 24.7% and 23.2% of the participants had depression and anxiety, while 42.2% faced
sleep disturbances, of which 17.4% experienced insomnia.
The authors studied the factors associated with suicide in India during COVID-19 in [53].
The data were collected using a web search for suicide news in Indian and international English
newspapers, which resulted in 34 completed suicides during the period from January 25 to April
18, 2020. The majority of the victims (52.94%) were young adults between 18 and 36 years old.
The reasons associated with suicide are fear of infection, misinterpretation of fever as COVID-19,
depression, loneliness, and perceived stigma of COVID-19 infection.
Reference [54] presents a study on human behavior and habits in Austria, Switzerland, and
Germany during COVID-19 lockdown. A total of 435 tests were obtained by individuals of
high socioeconomic status and high educational level to assess the quality and quantity of sleep,
the mid-sleep difference between working and free days, and life satisfaction. Advanced non-
parametric analysis revealed that the mismatch between social and biological sleep—wake timing
was reduced during the lockdown resulting from accomplishing more work from home. Sleep
quality was reduced by 0.25 points (0–25 scale); the subjective burden increased accordingly while
mental and physical wellbeing decreased. Sleep quality reduction was associated with social sleep
reduction and working hours.
Reference [55] reports on the analysis of psychological states. The data were collected using an
online survey containing questions related to sociodemographic conditions, contact with COVID-
19, and emergency conditions due to COVID-19. The results indicate that psychopathological
symptoms such as anxiety, mood alternations, and PTSD symptoms were found in 31.38%,
37.19%, and 27.72% of the participants, respectively. The causative factors include being female
under 50 years of age, having direct contact with COVID-19 infected patients, and uncertainty
about the risk of COVID-19.
Factors associated with coronavirus anxiety were studied in [56] using an online survey in Ger-
many. A total of 1615 participants (79.8% female and 19.8% male) completed the questionnaire
between March 15 and 22, 2020 for trait health anxiety, cyberchondria severity scale, emotion
regulation, and questions about the COVID-19 pandemic. The repeated ANOVA (rANOVA),
Spearman’s correlation coef cients, and rANCOVA (repeated measures analyses of covariance)
were used for analyses. The results indicated signi cantly high anxiety due to COVID-19 in indi-
viduals with heightened trait health anxiety. Cyberchondria indicated a correlation with anxiety,
while adaptive emotion regulation serves as a moderator to reduce anxiety.
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Reference [57] investigated the impact of COVID-19 on sleep disturbance and suicidal
thoughts using a Facebook survey in Taiwan. Several COVID-related factors were collected from
the participants, including anxiety level, social interaction patterns, study-related interference,
social support to combat the disease, and physical health. The majority of the participants (55.8%)
reported sleep disturbance, while a smaller portion (10.8%) admitted suicidal ideation. Factors
such as increased worry, changes in social interaction, impaired social support, severe academic
interruption, and poor physical health care are responsible for sleep distress problems. In addition,
suicidal thoughts are associated with less handwashing, lower social support, lower COVID-19
related support, poor physical health, and youthfulness.
Health factors related to psychological distress during COVID-19 in Spain were studied
in [58]. Bivariate analysis, chi-squared test, and Student’s t-test were used on the data collected
from 4180 people containing general health questionnaire-12. Psychological disorders were found
in 72% of the participants, with a higher percentage in women and lower middle-aged people. The
younger population lacks the resilience to face adversity and is more exposed to distress. Similarly,
people living with children experience high distress and psychological vulnerability. In addition,
the mental health of Chinese children and adolescents was analyzed in [59] during the COVID-19
outbreak. The questionnaire contained a Spence Child Anxiety Scale, Child Depression Inventory,
and Coping Style Scale, and 359 children and 3254 adolescents completed the questionnaire
online. Analysis indicated that 22.28% of the participants suffered from depression symptoms.
Anxiety was associated with being female, resident in urban regions, and an emotion-focused
coping style. Depression was linked with smartphone addiction, internet addiction, and residents
in Hubei province. Reference [60] presents a study that analyzed COVID-19 patients’ data for
anxiety and depression. Among the 1642 respondents in the survey, 23.1% experienced moderate-
severe anxiety, while 41% faced mild anxiety. Moderate depression was found in 48%, while 9.2%
faced moderate-severe depression. Students and the unemployed experienced higher anxiety than
non-students and the employed, respectively. Similarly, those with a preexisting psychiatric history
faced higher anxiety and depression.
The factors associated with sleep disorders include stress, less physical activity, alcohol intake,
cigarette smoking, age, marital status, depression, coronavirus anxiety, mood alterations, and
female sex.
3.5 Evaluation of the Discussed Methods
Numerous research studies have investigated the physical and psychological damage caused by
COVID-19 in general population as well as health workers and physicians. The results indicate
asthma, heart disease, suicidal ideation, and sleep irregularities. Predominantly, most of these
studies relate to mental health problems such as sleep disorders, stress, anxiety, and depres-
sion. Sleep and anxiety disorders are most commonly reported among those surveyed. However,
the percentage of victims varies by country and study because of the use of various analysis
techniques. Stress analysis and mental health problems were studied using surveys that omitted
many considerations. For example, these studies cover a single community, city, or country and
are limited because of regional differences, including demographic and socioeconomic conditions,
awareness, education level, and health system. Therefore, a survey designed for a speci c country
may not be suitable for other countries with different prevailing conditions. Questions answered
in surveys unintentionally may be biased or incorrectly answered because of a lack of knowledge
or understanding. Surveys involving children and adolescents are limited by the possibility that
the results and conclusions were inuenced by participants who required assistance from their
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guardians and the degree of understanding of the questions. In addition, the questions added
in the surveys and questionnaires were selected concerning their quantitative importance for
statistical analysis and restricted the participants from expressing their subjective views. In several
studies, the sample size was too small for the results to be generalized. Similarly, changing the
analysis technique might produce different results on the same data.
Tab. 3 provides a summary of the research works investigating the resulting problems from
COVID-19. Several previous studies suggest that viral infections are associated with a high risk
of exposure to other diseases such as anxiety, heart disease, lung disease, and mental disor-
ders [39–41]. Subsequently, many studies have focused on analyzing the impact of COVID-19 on
physical and mental health in infected areas. The  ndings of these studies suggest that asthma,
cardiac complications, and several mental health problems such as stress, anxiety, depression,
sleep disorder, and suicidal thoughts, are prevalent in people facing COVID-19, lockdown, and
other social interaction restrictions. Predominantly, such studies investigate mental health problems
such as sleep irregularities, anxiety, and depression, using surveys and questionnaires that are
lacking in several aspects. For the most part, these studies are designed for a single community,
city, or country. They do not apply to other countries owing to differences in demographics,
socioeconomic status, education, and health conditions. Moreover, the participants were hired to
complete surveys and questionnaires, and answers may be biased, incorrectly answered owing to a
lack of understanding, or by intention. Similarly, surveys requiring children’s response may not be
transparent because of guardian or parental inuence, apart from the degree of a child’s under-
standing. Additionally, the surveys and questionnaires were selected because of their quantitative
importance for statistical analysis, and participants’ subjective views were not recorded. Similarly,
the sample size for such surveys is too small for their results to be generalized.
Table 3: Summary of works studying the exposure of COVID-19 patients to other diseases




















2,993 Sleeplessness, depression, and
PTSD symptoms.
Direct exposure to COVID-19
infected area, exposure to
media.
[48] Survey (stress) 3,787 High-stress score (3.33), with
females age between 30–39
years, housewives.
The knowledge that there is no
vaccine, failure to obtain masks
and sanitizers, and individuals
with higher knowledge of risk.
[49] Questionnaire
(depression)
500 Depression (19%), anxiety
(14%), mental health
deterioration (25%).
Getting infected by COVID-19,
lack of suf cient masks, being
unable to work from home.
(Continued)
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Table 3: Continued
Ref. Methodology (aim) Sample Disorders found in the analysis Associated factors
[50] Survey (sleep
disorders)
1,491 Physical activity (48.9%),
sleep disorder (40.7%),
alcohol use (26.6%), smoking
(6.9%).
Physical activity, sleep,
smoking, and alcohol intake





442 Depression (64.7%), anxiety
(51.6% and stress (41.2%)
DAS is due to increased weekly
working, a higher number of
COVID-19 patients, lower level
of peer and supervisor support,
lower logistic support, and




1,515 Depression (24.7%), anxiety
(23.2%), sleep disturbance
(42.2% of which 17.4% face
insomnia)
Being female, time spent on the
internet, participants with
chronic disease, avoidance of
activities.
[53] Data from web
search (suicide)
34 High suicide rate (52.94%)
for adults (18–35 years) and
male (82.35%)
Fear of infection (47.05%),
misinterpretation of fever as
COVID-19 (26.47%), depression
and loneliness (20.58%),




435 Increased exibility of
working, reduced sleep
quality 0.25 (on a scale of
0–25), and reduced mental
and physical wellbeing.






anxiety (37.19%), and PTSD
(27.72%)
Females, people under 50 years









Trait health anxiety and
Cyberchondria (excessive
health-related internet search)
are risk factors while
information about the
pandemic and adaptive emotion




1,970 High psychological disorders
among 72%, women, and
young people face high risk.
Young people’s inability and
experience in facing
vulnerability is the root cause.





4,180 Psychological disorder (72%),
women, and younger people
are at higher risk.
Lack of resilience to face
adversity, living with children.
(Continued)
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Table 3: Continued




359 Depression symptoms in
22.28% of participants.
Being female, resident of urban
regions, smartphone addiction,





1,642 Moderate-severe anxiety and
depression in 23.1%, 9.2%,
respectively.
Youth, unemployment, being a
student, and having a lower
quality of life are associated
with anxiety and depression.
4 Impact of Various Diseases on COVID-19 Infection Level
Several observational and retrospective studies that analyze the impact of viral infection
suggest the prevalence of various underlying conditions such as asthma, diabetes, and heart
disease and con rm severe outcomes and complicated medical conditions [40,61]. As a result, it is
highly desirable to investigate the role of preexisting medical conditions in the severity and fatality
of COVID-19 patients. Multitudinous works that focus on analyzing the impact of underlying
medical conditions on the outcome of COVID-19 patients can be found in the literature.
4.1 High Cholesterol
The impact of high cholesterol on the infectivity of COVID-19 was analyzed in [62]. Analyses
revealed that COVID-19 patients with CVD, hypertension, and obesity seem to have severe clinical
conditions. Similarly, the authors in [63] suggested that patients with CVD disease are highly prone
to COVID-19 infection, especially with CVD originating from atherosclerosis. Another research
work [64] investigated the connection between COVID-19 and cholesterol metabolism. Analysis
indicated that triglycerides (TGs) and high-density lipoprotein cholesterol (HDL-C) levels were
lower in patients with severe COVID-19 illness. Along the same lines, research [65] states that
lower free cholesterol (FC), high-density lipoprotein (HDL), and low-density lipoprotein (LDL)
are associated with COVID-19 patients than those those not infected.
4.2 Cardiovascular Disease
A summary of the health records of 72,314 COVID-19 patients from China was analyzed
in [66]. It has been reported that the fatality rate is higher for COVID-19 infected cases with
preexisting medical conditions such as CVD, diabetes, and respiratory disease. Patients with CVD
are at higher risk, with a fatality rate of 10.5%, followed by diabetes, chronic respiratory disease,
hypertension, and cancer with a fatality rate of 7.3%, 6.3%, and 5.6%, respectively. Similarly, the
authors investigated 187 patients with COVID-19 [67] for the impact of underlying CVD and
myocardial injury on the fatal outcome. Analyses indicate that the fatality rate is higher (13.33%)
for COVID-19 patients with CVD than for those without CVD (7.62%). CVD is associated with
fatal outcomes in COVID-19 patients; however, myocardial injury has a signi cant association
with fatality compared to CVD without myocardial injury.
Other studies [68,69] suggest that patients with a high prevalence of CVD are more severely
ill when infected with COVID-19 than those with mild CVD disease. Similarly, non-surviving
COVID-19 patients had critical CVD compared to survivors at the hospital in China during
the start of the outbreak [70]. Two similar studies [71,72] that investigated clinical features in
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COVID-19 patients with the data of 150 and 191 COVID-19 admitted patients indicate that the
fatality rate is high for patients with coronary heart disease. Similarly, Italian COVID-19 patients’
data show that three or more preexisting chronic CVDs are present in approximately 60% of the
deaths [73,74]. Such conditions include hypertension, coronary artery disease, and diabetes.
4.3 Hypertension, Diabetes, and Kidney Disease
The authors studied the clinical pro les of 204 elderly patients admitted with con rmed
COVID-19 in [75]. The results indicate that besides age, hypertension is highly associated with an
increased risk of death. Other disease conditions that contribute to the elevated risk of mortality
are CVD, diabetes, COPD, malignant tumors, and kidney disease. Patients with lung, heart, and
kidney disease are highly vulnerable to COVID-19. Similarly, the data for 87 elderly people were
collected from a nursing home to study the characteristics of COVID-19 in [76]. It was found that
the probability of COVID-19 infection is 100% for people younger than 90 years with dyspnea
and falls, people older than 90 with anorexia, and people older than 90 without anorexia but
with altered dementia. Similarly, [77] analyzed the data of 2968 patients from Iran to analyze the
impact of underlying diseases on the outcome of COVID-19 patients. Findings indicate that a
higher age group is at a higher risk of COVID-19 infection. Older people with preexisting diabetes,
chronic respiratory diseases, hypertension, CVD, chronic kidney diseases, and cancer have a higher
associated risk of complicated COVID-19 infection and mortality. In the same vein, the authors
performed analyses on 14,712 patients with 43.7% females and 56.3% males in [78]. Statistics
suggest that male patients are older (55.0 ± 17.7). A high prevalence of hypertension, diabetes,
coronary disease, obstructive pulmonary disease, nicotine dependence, and heart failure is found
in COVID-19 victims.
The analyses of 1591 con rmed patients with COVID-19 in [79] revealed that 31.99% of
the patients had hypertension. Hypertension is found in a higher number of older patients than
younger people. Similarly, the authors analyzed the data of 2634 patients (out of 5700 admitted)
who died or were discharged during the COVID-19 outbreak in [80]. Evidence shows that diabetics
are more likely to require mechanical ventilation. The death rates for patients requiring mechanical
ventilation in the age groups 18–65 and older than 65, respectively were 76.4% and 97.2%.
Similarly, the inuence of diabetes leads to acute kidney injury compared to patients without
diabetes. The most common comorbidities found in COVID-19 patients were hypertension, obesity,
and diabetes, with 56.6%, 41.7%, and 33.8%, respectively. Similarly, a study [81] conducted on 161
COVID-19 con rmed patients in China investigated underlying comorbidities. Analysis indicated
that hypertension was found in 23.0% of the patients, while 8.0% had diabetes. Another 5.3% had
coronary heart disease, while 7.1% of the patients were current smokers. Exposure to patients with
the con rmed disease is likely to increase the infection rate. Prolonged treatment is associated with
preexisting hypertension.
The data for 2634 patients who died or were discharged showed that 12.2% required mechan-
ical ventilation, of which 76.4% and 97.2% died for 18–65 years and older than 65 years,
respectively. The mortality rate for those who did not receive mechanical ventilation was 1.98%,
26.6% for 18–65 years, and older than 65 years of age groups. The study revealed that older men
are highly exposed to COVID-19, similar to those with preexisting hypertension and diabetes.
Several studies have investigated the impact of preexisting kidney disease on severe illness
and mortality in COVID-19 patients. For example, the author studied kidney abnormalities in
701 con rmed patients with COVID-19 [82]. Approximately half of the admitted patients (42.6%)
had one or more comorbidities such as chronic kidney disease, chronic obstructive pulmonary
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disease, hypertension, diabetes, and tumor, of which kidney patients constituted 2.0%. High serum
creatinine was reported in 14.4% of the admitted patients, who were predominantly male, older,
and seriously ill than those with normal serum creatinine. Similarly, another study that explored
the clinical characteristics of 155 patients in China revealed that 45.8% of the patients had at
least one preexisting disease, such as hypertension (23.9%), kidney disease, diabetes (9.7%), and
CVD (9.7%) [83]. The authors state that obesity signi cantly increases the risk of complicated res-
piratory disease and COVID-19 infection [84]. Analysis performed on 214 patients with con rmed
COVID-19 suggests that patients having MAFLD (Metabolic Associated Fatty Liver Disease) have
metabolic risk factors and may lead to severe respiratory disease. Of the patients with severe
COVID-19, 89.5% were more obese than those with mild disease. A six-fold increased risk of
critical illness was associated with COVID-19 patients with MAFLD.
4.4 Analysis and Findings
The  ndings of the above-discussed studies indicate that COVID-19 patients with preexisting
CVD are at high risk of developing a critical illness or death. Despite this, there is no single
CV factor responsible for such complications. Moreover, the data  ndings are from two or three
countries and may not apply to other countries with different age groups and living and health
conditions, such as South Korea. Many of the studies are retrospective and are limited by selection
bias, health conditions, and care-seeking behaviors. The mortality rate found in many of the
studies was higher than that of the average mortality rate for COVID-19, suggesting that a large
percentage of the included data is from hospitalized patients and those quarantined with mild
symptoms are not taken into account. Studies indicate that patients with CVD should be placed
under special consideration to avoid severe illness.
Multiple studies suggest that the prevalence of preexisting medical conditions, such as asthma,
diabetes, and hypertension, complicates the illness and the probability of death for COVID-19
patients. As a result, numerous researchers have studied the impact of various medical conditions
on the severity and fatality of infected patients. Results indicate that patients with preexisting
CVD are at an elevated risk of severe illness and death. Similarly, underlying kidney disease
leads to higher chances of mechanical ventilation. Hypertension is another medical condition
associated with a higher risk of death. Diabetes, malignant liver disease, and cancer patients are
prone to grave danger from complicated medical conditions and death if infected by COVID-19.
Though such studies’  ndings are helpful for medical experts and policymakers to consider when
making plans to tackle the COVID-19 outbreak, they are restricted by a few limitations. In most
instances, research  ndings are from two or three countries. Many important elements such as
health conditions, living conditions, demographics, and personal information, are not considered
for analysis, limiting their wider application. Similarly, studies that are retrospective by nature
may be biased because of selection, health conditions, and care-seeking behaviors. Fatality rates
are calculated without considering the outputs of all admitted patients and may be exaggerated.
People in quarantine, being asymptomatic, and with mild conditions are not included thus limiting
the scope of the analysis.
High cholesterol, preexisting CVD, hypertension, diabetes, and kidney disease are associated
with a higher risk of severe illness and fatality in COVID-19 patients. Such indicators can
potentially be used to measure the level of illness and the probability of death.
CMC, 2021, vol.67, no.3 3027
5 Disparity of COVID-19 Cases for Different Age Groups and Gender
Emerging evidence suggests that the risk of developing COVID-19 infection varies by age
group and gender. Consequently, studies across a broad spectrum were conducted to evalu-
ate these hypotheses. Such studies may be broken down into three broad categories: studies
that investigate the impact of age on COVID-19 risk, studies that analyze the vulnerability to
COVID-19 by gender, and studies investigating other factors that may explain the probability of
getting COVID-19, such as pregnancy and age peer group. In the following sections, the research
works and their  ndings are discussed for each category.
5.1 Impact of Age to Combat COVID-19
A scoping study [23] of 10,840 patients from South Korea points out the impact of age and
gender on the death rate from COVID-19. The female infection rate was higher (59.35%) than
that of males (40.65%); however, the fatality rate is higher for male patients, that is, 3.02% vs.
1.91% for females. Similarly, the death rate is higher for people aged 80 years or older (25.00%),
followed by those aged 70–79 years (10.85%). The authors analyzed the data of 5700 patients with
COVID-19 from the US for preexisting conditions resulting in complicated illness [80]. The data
for 2634 patients who died or were discharged showed that 12.2% received mechanical ventilation,
of which respectively 76.4% and 97.2% in the 18–65 cohort, and the older than 65 cohort, died.
The mortality rates for those who did not receive mechanical ventilation were 1.98%, 26.6% for
the 18–65, and older than 65 age groups.
Age plays a vital role in combating COVID-19 infection, and [75] studies the impact of
greater age on the outcome of COVID-19 patients, where a sample of 204 con rmed patients
was analyzed. The age of all patients was above 60, with a median age of 68. Upon initial
admission, 64.7% of the cases were mild. Analysis results show that age and underlying diseases
are associated with high fatality risk. Despite the lower mortality rate of COVID-19, a higher
fatality rate of 37.3% is associated with patients aged > 60 years. Another study in the same
direction was [85], in which the characteristics of greater age were investigated in COVID-19
patients. The data for 339 patients aged between 60 and 80 years admitted to a hospital were
analyzed. The results revealed that the fatality rate for elderly COVID-19 patients is high, and
19.2% of the sample size died after a short stay in the hospital. The factors associated with a high
fatality rate are symptoms of dyspnea, CVD, chronic obstructive pulmonary disease, and acute
respiratory distress syndrome.
The authors performed COVID-19 screening and study characteristics in [76] for a nursing
home with 87 older people and 92 staff members. The results show that the residents and staff
have different attack rates of 47% and 24%, respectively. The mortality rate for older people
studied in the research was 15%, which is higher than the average reported rate (2%–3%). Refer-
ence [60] also presents an analysis of COVID-19 patients’ data for exploring the impact of age
and gender. The Mann–Whitney test shows that women have higher anxiety and patient health
questionnaire-9 scores than men. The Kruskal–Wallis H test indicates that younger people (18
to 29 years) face the highest anxiety and depression. Students and unemployed experience higher
anxiety than those of non-students and employed, respectively. Similarly, people with a preexisting
psychiatric history face higher anxiety and depression. Younger people prove to be less compliant
with precautionary measures.
The data of 17,305 patients were analyzed in [86] to  nd the correlation between the age
group and its impact on the recovery and fatality rates for COVID-19. The results show that
clustering related ages is more explanatory than by country. The cluster with higher infections
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belongs to the 30–40 years range. Similarly, it was found that recovery rates are higher in the
Asian, EU, and UK groups. Additionally, higher fatality rates are found for the Middle East and
North American groups, and females have lower fatality rates than males in Asia, the EU, and
the UK. Another work [79] reviewed the data of 67 con rmed patients with COVID-19 who
were aged 75 years to study short-term outcomes of being discharged, not discharged, and death.
Statistics revealed that 96.7% of the patients suffered from pneumonia, 90.3% required oxygen
supplements, and 25.8% underwent invasive ventilation. A total of six deaths occurred among 67
patients because of acute respiratory distress syndrome worsened by septic shock and heart injury.
Results showed that patients aged ≥65 years had severe outcomes.
The data for 1591 con rmed patients of COVID-19 were analyzed in [87] for Italy to inves-
tigate the important characteristics of the patients. The majority of the patients were 56 to 70
years old, and males constituted 82% of the total patients. Respiratory support was provided
to approximately 99% of patients with 88% mechanical ventilation and 11% with noninvasive
ventilation. Older patients aged ≥64 years have a higher mortality rate of 36% than those aged
≤63 with a mortality rate of 15%.
5.2 Vulnerability of Gender Group for COVID-19
Apart from age, the outcome of COVID-19 by gender has been investigated in many analytic
studies. For example, the authors perform a comprehensive analysis of the available data from
various databases, online news, and published articles on how gender is related to COVID-19
in [88]. The results indicate that South America, NY, and Asian countries experience higher
COVID-19 cases associated with males, except for South Korea. In global Europe, the infection
rates for males and females are comparable. Another study [89] investigating symptomatic and
asymptomatic cases for the initial outbreak in China showed that the infection rate is higher for
females. The male infection rate was 42.6%, while 57.4% of females were infected with COVID-19.
However, males tend to be highly asymptomatic (54.5%), while females experience symptomatic
features when infected with COVID-19.
The study [90] investigated the inuence of gender on COVID-19 outcomes using data
from multiple sources such as hospital patients (43), public datasets (37), and the dataset of
surviving patients from China (1019). The analysis revealed that greater age and multiple comor-
bidities proved to be fatal for COVID-19 patients. Even though men and women are prone to
COVID-19, men are at a higher risk for worse outcomes, with a fatality rate of 2.4 times that
of women. Along the same lines, the authors performed an analysis to assess the extent of lung
injury in men and women with COVID-19 [91]. Results show that heart disease is more prevalent
among men, with a rate of 27.2% against 13.3% in women. CT  ndings showed a higher severity
score for men than for women. The study corroborates that men are at a higher risk of death
than women.
The role of sex and gender on the outcome of COVID-19 was studied in [92] for 4880
patients with respiratory symptoms or close contact with COVID-19 con rmed patients in Wuhan,
China. A total of 38.42% of these people tested positive for COVID-19. The analysis shows that
higher infection rates are associated with gender and age; among the suspected cases older males
had a signi cantly higher risk of developing COVID-19 infection. Similarly, gender disparity was
analyzed in [93] for COVID-19 patients. The study considered age and sex to analyze the outcome
for COVID-19 patients. Results indicate that a higher mortality risk is associated with males.
Similarly, the risk of hospitalization and mechanical ventilation is higher for male victims. The risk
of death and comorbidities is higher in male patients than in female patients, even for the same
CMC, 2021, vol.67, no.3 3029
age group. The gender-based risk of fatality is higher in men of higher age. Additionally, a higher
risk of ICU admission is associated with male patients than female COVID-19 patients [94].
On a similar note, a cohort study is presented in [77] on the data of 2968 patients in Iran. The
results suggest that male patients are at higher risk of death than female patients with COVID-19.
Being male, of greater age (60 and higher), and having underlying diseases are associated with a
higher probability of mortality. In the same way, the research [95] indicates that although both
men and women are victims of COVID-19, the difference lies in mortality and vulnerability to
the disease. Results suggest that the male fatality rate is higher than the female, potentially based
on immunological or gendered differences.
Reference [78] presents a study on the role of gender in surviving COVID-19, wherein the
data of 14,712 patients were analyzed. A higher number of older men were found among patients
with various preexisting diseases. Evidence indicates that the mortality rate among males is 8.8%
and females (4.3%). Additionally, the probability of survival for males is signi cantly lower than
that for females, at 74% and 86%, respectively. In the same vein, the authors assess the data of
patients from Mexico in [96]. The concept of adjusted lethality is used to describe the probability
of death for various age groups, for males and females, separately. Statistics show that the highest
risk of mortality is for the age group 60 or higher for both males and females. Additionally,
lethality among males is approximately 100% higher than for females, even within the same
age group.
Besides males and females, homosexuals also have associated risk factors, mental problems,
and special needs amidst the COVID-19 crisis. Reference [97] indicates that because of social
barriers based on binary gender norms, transgender people face an increased risk of illness
and mortality during COVID-19. Additionally, transgender adults already face underlying med-
ical problems that increase their vulnerability to COVID-19 and may lead to severe illness or
death [98]. In the US alone, a total of 319,800 transgender adults face one or more diseases, such
as asthma, diabetes, heart disease, and HIV. Another study [99] investigated physical and mental
problems in lesbian, gay, bisexual, and transgender (LGBT) community showed that 45.7% of
LGBT college students confused about their identity and almost 60% of LGBT college students
face psychological distress, anxiety, and depression during COVID-19.
5.3 Vulnerability of Various Blood Groups to COVID-19
Besides age and gender, two additional study lines are the vulnerability of various blood
groups and the probability of COVID-19 in children born from COVID-19 infected mothers.
Therefore, the impact of COVID-19 on newborns was analyzed in [100] using the medical data
of 755 pregnant women and 598 infants. The authors state that there is no evidence of vertical
transmission based on the  ndings of the study. Among the 493 infants tested for COVID-19,
only 2% were found to have the disease. The inuence of a speci c blood group is important
to tackle COVID-19; therefore, the authors studied the relationship between blood group and
COVID-19 patients’ characteristics in [101]. The study identi ed that among 187 patients selected
for analysis, type A blood patients were signi cantly higher (36.90%). People with type A blood
have the highest risk of infection. Conversely, those with O blood groups have a lower associated
risk of being infected with COVID-19.
5.4 Critical Appraisal of Discussed Works
The data selected for COVID-19 patients were predominantly obtained from hospitals. The
proportion of severely and critically ill patients may be higher than those of other hospitals in
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different countries with different living and health conditions. The fatality rate may differ from
that of the entire infected population in a country. Similarly, the data collected from various nurs-
ing homes and other similar institutions may not be fully representative of the general population.
The residents isolated in such institutions do not suffer from the same cognitive disorders as the
common population.
Table 4: Summary of  ndings of works that study the inuence of gender on COVID-19
Ref. Sample Aim Findings of the analysis
[23] 10,840 Infection and death rate
for age group and gender.
High infection and death rates for females & males,
respectively, were 10.85% and 25.00% for people aged
between 70–79 and 80 and above.
[60] 1,642 Impact of age on anxiety
and depression.
Youth, unemployment, and being a student are
associated with high anxiety and depression; young
people have high non-compliance with precautionary
measures.
[77] 2,968 Impact of age and gender
on COVID-19.
Male, older, and preexisting chronic disease are
associated with a higher death rate.
[78] 14,712 Survival probability for
males and females.
Males have a lower probability of surviving COVID-19
(74% vs. 86% for females), the mortality rate for men is
higher (8.13% vs. 4.60% for females).
[79] 67 Short-term outcomes for
people with 75 years and
Higher.
96.7% suffer from pneumonia, 90.3% require oxygen,
25.8% need invasive ventilation.
[80] 5,700 Risk factors for COVID-19
by age.
Age above 65 is associated with a higher mortality rate;
the death rate is higher for those who receive
mechanical ventilation.
[87] 1,591 COVID-19 characteristics
among elderly patients.
High oxygen support, mechanical ventilation, and
mortality rate of 36% for patients aging ≥64 years.
[90] 1,099 Gender difference and
COVID-19.
Men with COVId-19 face a high risk of worse outcomes
and death, the death rate for men is 2.4 times higher
than those of women.
[91] 216 The extent of lung damage
for men and women.
The rate for heart disease in men is 27.2% than that of
13.3% in women. Lung damage is severe for men.
[92] 4,880 The infection rate in
gender and age.
Infection rate varies with gender and age, male and old
people are at a signi cantly higher risk of COVID-19
infection.
[93] 13,710 Role of gender and age on
COVID-19 outcome.
Male patients have a higher fatality, hospitalization,
ventilation risk than female patients of the same age
group.
[96] 34,686 Lethality of COVID-19 by
age group and gender.
The 60 and higher age group is at the highest risk,
males have higher lethality even within the same age
group, i.e., adjusted lethality (0.00822 vs. 0.00432 for
females).
[101] 187 Relationship between
blood group and
COVID-19.
People with blood group A are highly vulnerable to
COVID-19 while those with O are less prone to
infection.
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Tab. 4 imparts a critical appraisal of the research works that study the role of age groups
and gender in combating the COVID-19 pandemic. The impact of age groups and gender is an
important factor that may indicate the susceptibility of COVID-19 infection. A broad spectrum
of research focuses on the relationship between age groups and gender and their vulnerability
to COVID-19 infection and death. Evidence and  ndings of these studies suggest multifarious
views about the vulnerability of males to severe illness and death. Many studies have revealed
that males have a higher associated risk of COVID-19 infection. Additionally, the mortality rate
is higher for male patients admitted with COVID-19. The likelihood of fatality is higher when the
age is 60 years or higher among both males and females; however, males are at higher associated
risk. When greater age is associated with preexisting medical conditions such as diabetes, CVD,
hypertension, and lung disease, the probability of a severe outcome is even higher. Various blood
groups have different vulnerability levels to COVID-19, where blood group A patients are at a
signi cantly elevated risk of death. Despite the  ndings of these studies, several factors undermine
their importance. The data used for analysis are often collected from hospitals and clinics caring
for severely ill and critical patients. Such inclusion of the data may be potentially higher than
those with mild symptoms and quarantined patients, resulting in overstating the fatality rate. The
data collected from hospitals may not reect the general population, and the results may vary
signi cantly if the data for all those infected are considered. Similarly, data from a different
country with different health and social conditions may change the results dramatically.
Greater age is associated with an elevated risk of COVID-19 infection and fatality. Various
age groups have different risk factors for COVID-19. Females are found to be less vulnerable
than males to COVID-19 infection. Similarly, transgender adults have a higher associated risk
concerning their preexisting medical conditions.
6 Prediction of Mortality and Severity of COVID-19
Coping with the accelerated pace of fast-spreading COVID-19 requires analyzing the risk
of deterioration, assessing the underlying comorbidities, predicting the probability of death or
critically ill patients, and stratifying patients to manage them accordingly. By analyzing the clinical
characteristics of COVID-19 patients to identify predictors of critical care admission and death is
an important task that can facilitate the task of health professionals and save lives. Mortality or
critical condition prediction involves analyzing several factors such as age, gender, comorbidities,
respiratory capability, and oxygenation. Several studies can be found in the literature on the role
of such indicators in predicting mortality and critical care admission for COVID-19 patients.
There are several types of studies that focus on COVID-19 severity of illness and mortal-
ity. Among the most widely conducted investigations is the analysis of factors associated with
aggravated illness and elevated mortality and analysis of CFR and infection fatality rate (IFR)
comparison among various countries. The following discussions are categorized under the groups
mentioned above.
6.1 Risk Indicators to Predict Fatality and Severity of Illness
The authors performed the analysis on 1,157 con rmed COVID-19 patients in [102] to predict
patients at high risk of critical care or death. The risk score for death or severe condition was
calculated by incorporating 12 factors such as age >40, male, non-white, oxygenation <93%,
radiological severity score >3, neuropathic count >8.0109/L, CRP >40 mg/L, albumin <34 g/L,
creatinine >100 mmol/L, diabetes, hypertension, and chronic lung disease. A risk score of 4
indicates a 40.7% risk of death higher than the 12.4% for patients with a risk score of less than
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4. A higher risk score is associated with critical care admission of a longer duration. Similarly,
the authors performed a detailed chart overview in [103] for 355 patients who died of COVID-
19 in Italy. The majority of the fatalities were older with a median age of 79.5 years and
male (70%). The high-risk factor identi ed during the analysis was underlying co morbidity and
greater age. COVID-19 patients with diabetes have a higher association with death, with a rate
of 35.5%, followed by active cancer, CVD, atrial  brillation, stroke, and dementia with death
rates of 30.0%, 24.5%, 20.3%, 9.6%, and 6.8%, respectively. Of the patients who died, 25.1%,
25.6%, and 48.5% had one, two, and three or more underlying diseases, respectively. An additional
supporting study [104] suggests that a higher fatality rate is found in COVID-19 patients aged
60 years or older. A study of 1560 cases indicated that 31.5% of total deaths result from cancer,
other underlying diseases, or severe infections. It was also stated that the fatality rate is higher for
patients with mixed bacterial infection and basic disease.
Sardinia, an Italian island, was selected for epidemiological studies owing to its geograph-
ical characteristics and genetic homogeneity [105]. A sample of 1223 COVID-19 patients was
selected to study potential risk factors for the disease’s  nal outcome. Approximately 98.9% of
the deceased patients carry underlying health conditions. Elderly people are at higher risk of
death, as the analysis indicates that 83.5% of the deaths are aged 70 or more. The CFR for
men is almost double that of women, that is, 10.4% vs. 6.2%, respectively. The high-risk factor is
associated with COVID-19 patients with underlying diseases such as CVD, chronic neurological
diseases, chronic lung diseases, and diabetes mellitus. Similarly, it was pointed out in [106] that
hypertension, diabetes, and chronic kidney disease have an elevated risk of death in COVID-19
patients. Additionally, the analysis of 5,152 patients suggests that other comorbidities such as
asthma, HIV, and cancer lead to severe illness and critical care is required for recovery. Other
parameters that are useful to determine the risk of death for COVID-19 patients are age, sex,
respiratory rate, oxygen saturation level, systolic blood pressure, and maximum temperature.
In the same vein, the demographic and clinical characteristics of 417 patients were studied
in [107] to build a model for predicting the severity of COVID-19 illness. The  ndings indicate that
of the patients who took more than 20 days to recover, the majority were in the 50 or older age
group. Four risk factors were identi ed, namely, age, body mass index (BMI), CD4 T lymphocytes,
and IL-6 levels. Severe illness occurred in patients with age >55 with BMI >27 kg/m2, IL-6
>20 pg/mL, and CD4 T cells >400 mL. A lower platelet count requires a longer recovery time.
Similarly, underlying chronic liver disease, hypertension, diabetes, and CVD medical conditions
were found in 8.4%, 7.6%, 4.8%, and 2.8% of the patients, respectively. In a similar study [108],
which focused on the severity and CFR of COVID-19 patients, the data of 2547 patients in
India were studied for underlying risk factors that lead to severe illness or death. Disease fatality
rates (DFRs) were used to analyze the lethality of particular underlying diseases for COVID-19
patients. The analysis indicated that diabetes in COVID-19 Indian patients is associated with a
death rate of 39.4%, followed by CVD, hypertension, respiratory problems, kidney disorders, and
liver ailments with rates of 33.3%, 25.8%, 15.2%, 10.6%, and 3.0%, respectively.
A study incorporating longer-term baseline mortality was presented in [109], where the under-
lying health conditions were integrated to estimate 1-year mortality with different infection rate
scenarios. By considering the data of 3,862,012 people, the study suggests that 20% of the total
population is at high risk of catching COVID-19 in the UK. People older than 70 and having
at least one co morbidities are at higher risk of death from COVID-19. In a mitigation scenario
where the suppression rate is 10%, 73,498 additional deaths are expected with a relative risk of 3.0.
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6.2 Analysis of Infection and Case Fatality Rates
An analysis of the case fatality rate was performed in [110] to compare the mortality of
COVID-19 between Turkey and European countries to understand epidemiological patterns. Fif-
teen days of data were selected from Turkey, and regression analysis was carried out to compare
CFR between Turkey and Italy, Spain, the UK, France, Germany, Switzerland, Belgium, Austria,
Netherlands, and Portugal. Analysis indicates that Turkey faces a similar CFR (1.85) as France
(1.979). However, increasing the data for two more weeks suggests that other selected countries
have a subsequent increase in CFR. A total of 40,835 con rmed patients and 1,620 deaths were
analyzed in [111] to investigate the IFR and crude fatality rate (CrFR) for 134 US counties.
CrFR varies from 1.7% to 33.3%, while the IFR rate varies between 0.5% and 3.6% for various
counties. Variations in CrFR and IFR are a result of several demographic factors like age,
gender, as well as, levels of population health, and provision of health care. Risk mitigation
factors, such as social distancing and self-quarantining, have been reported to decrease IFR.
In the absence of these strategies and because of the lack of health care supplies, the US is
expected to experience 500,000 deaths this year from COVID-19. Similarly, the authors performed
a mechanistic-statistical approach to infer the IFR from the data of infected cases in France [112].
Data from 10,612 con rmed cases and 1015 deaths were used for analysis. The IFR for hospital-
counted deaths is 0.5%, while the CFR is 2% for the number of deaths which is higher than
the diagnosed cases. Considering the number of deaths in nursing homes, the IFR would rise to
0.8%. Based on the analysis results, if 80% of the French population is infected with COVID-19,
a death toll of 336,000 is expected from the general population, that is, without considering the
number of deaths occurring in nursing homes.
6.3 Critical Evaluation of the Discussed Works
Many studies assume that the identi ed cases are symptomatic. However, substantial numbers
of infected persons are reported to be asymptomatic [113]. As a result, the reported infection or
death rate may be overstated. Similarly, the reported infection rate and CFR are not adjusted
for age groups and comorbidity as the data for comorbidity pro les are not available. Similarly,
the analysis of patients’ data whose outcomes are not available yet potentially varies from precise
estimates when all the cases are available. Moreover, CFR is a poor measure to indicate the
fatality risk of COVID-19 because of several important factors, such as demographic and health
conditions. For example, a high CFR for a country with low population density means lower
expected deaths and this may not be alarming for a small country. On the contrary, even a
lower CFR for countries with high population density, such as China and India, indicate a higher
mortality risk for such countries.
Predominantly, the models used for analyzing the risk factors are based on death over a
short period for example, the number of fatalities over days, the majority of whom report
underlying diseases. Such models neither integrate factors indicating high-risk conditions nor
consider long-term mortality. Researchers lack complex models that consider various categories
such as asymptomatic cases, unobserved symptomatic cases, observed symptomatic infectious, and
infectious diseases without any link to con rmed cases. The application of such models would
make it possible to predict the fraction of severity and fatality cases for COVID-19.
Getting to grips with COVID-19 involves the analysis of preexisting comorbidities and pre-
dicting the chances of critical illness and death so that it would be possible to stratify the patients
who require intensive care and treatment. For this purpose, studies bring to light important
indicators that can determine the probability of complicated medical conditions and death for
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medical experts to act accordingly to save lives. Such studies follow two plans of action: analyzing
various factors among COVID-19 patients associated with illness and death and studying case
fatality and infection fatality rates to establish a link between infection and fatality. In this
process, various analytical approaches such as descriptive analysis, ratio analysis, and cohort study
are used to analyze the clinical and demographic characteristics of COVID-19 patients. Many
proposed models perform well for predicting the fatality of COVID-19, but they have several
limitations. For example, the data used for the analyses were not adjusted for various age groups
and comorbidities and proved to be less informative. The reported CFR and IFR may be excessive
because of the exclusion of asymptomatic patients from the analysis. Matrices like CFR and IFR
are not appropriate without considering demographic and health conditions such as population
density and population age pro les. Using short-term data is yet another limitation, where the
majority of the dead victims have preexisting medical complications. High-risk conditions and
long-term mortality are not incorporated in such models. Similarly, simple models do not integrate
various categories such as asymptomatic cases, infection scenarios, government interventions, and
social interaction policies. Without the inclusion of such parameters, the results of these studies
prove to be inadequate with insuf cient information. Tab. 5 discusses the risk factors found in the
works mentioned above and elaborates on their  ndings.
Table 5: Findings of works analyzing the risk of death and critical care admission for COVID-19
Ref. Sample Risk indicators Findings of the analysis
[102] 1,157 Age >40, male, non-white, oxygenation
<93%, radiological severity score >3,
netrophic count >8.0× 109/L, CRP
>40 mg/L, albumin <34 g/L, creatinine
>100 µmol/L, diabetic, hypertension,
lung disease.
Risk score 4 has a high risk of death, 40.7%,
and is associated with a 28-day cumulative
incidence of admission for critical care.
[103] 355 Underlying comorbidities like diabetes,
cancer, CVD, and atrial  brillation have
a death risk of 35.5%, 24.5%, 20.3%,
and 9.6%, respectively. The elderly and
males face a higher risk of death.
One or more preexisting co morbidities have
a high associated risk of mortality for
COVID-19 patients. Patients with 3 or more
preexisting diseases have a mortality risk of
48.5%.
[104] 1,560 The fatality rate is higher for patients
who experience mixed bacterial infection
and basic disease.
The majority of those who died of
COVID-19 had cancer, major infection, and
other underlying diseases.
[105] 1,223 Patients aged 70 or higher are at higher
risk of death. Underlying chronic
diseases increase lethality
98.9% of the total deaths are those who had
preexisting diseases like CVD, chronic
diseases, and diabetes.
[106] 5,152 Age, gender, respiratory rate, oxygen
saturation level, systolic blood pressure,
and maximum temperature are risk
factors for determining patient
outcomes.
Underlying diseases like CVD, chronic
diseases, and diabetes are likely to increase
mortality for COVID-19 patients.
[107] 417 Higher age, BMI, CD+4 lymphocyte, and
lower IL-6 lead to severe illness for
COVID-19 patients.
More than 55 years of age and BMI
>27 kg/m2, IL-6 ≥20 pg/ml, and CD+4 T cell
≤400 count µL. Co-existing chronic diseases
increase the probability of severe illness.
(Continued)
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Table 5: Continued
Ref. Sample Risk indicators Findings of the analysis
[108] 2,547 CFR is associated with underlying
diseases like diabetes, respiratory, and
kidney ailments.
DFR diabetes, CVD, hypertension,
respiratory problems, kidney disorder, and
liver ailments are 39.4%, 33.3%, 25.8%,
15.2%, 10.6%, and 3.0%, respectively.
[109] 3,862,012 Higher age of at least 70 years or higher
with at least one underlying disease.
1-year mortality rates for COPD, chronic
kidney disease, CVD, and diabetes are
13.6%, 11.5%, 10.4%, and 8.9%, respectively
for those older than 70 and male.
[110] 13,531 Understanding epidemiological patterns
through CFR analysis.
CFR pattern is similar for EU countries at
the beginning of the disease; subsequent
analysis indicates a rapid increase in CFR.
[111] 40,835 Demographics patterns and IFR &
CrFR for COVID-19.
Absent mitigation policies and lack of
healthcare supplies increase the risk of
fatality.
Studies that predict the fatality rate and level of illness focus on two aspects of
COVID-19 patients: risk indicators that are useful for prediction and predicting the number of
infected patients and fatality rates. Risk indicators include age, ethnicity, and preexisting medical
conditions such as diabetes, hypertension, and chronic lung disease. The risk of death increases
with an extended duration of critical care and the presence of multiple medical conditions. The
CFR varies between 1.7% and 2, while CFR ranges between 1.7% and 33.3% from one country
to another.
7 Future Research Directions
Despite government intervention policies to ensure directed social interaction behaviors and
preventive measures taken at either the collective level, the pace of COVID-19 spread is not
reducing, as expected. In such scenarios, modeling approaches, paradigms, and algorithms that can
help research both positive and negative factors related to COVID-19 transmission and prevention
are of great importance. Future work directions are critical to reduce substantially the spread
of COVID-19 and hasten the recovery of those infected. Fig. 2 illustrates important areas that
necessitate research contributions from various research communities to enhance the ef cacy and
ef ciency of prediction and analysis approaches for COVID-19.
7.1 Models Prediction Number of Patients of COVID-19
Current SIR models used for predicting COVID-19 patients are used for a speci c city or
country, and the forecasts are short-term predictions spanning only a week or a month. Although
few studies use SIR models for long-term predictions their accuracy is minimal. Moreover,
multi-dimensional data reecting spatio-temporal diversity are not used for prediction. Dataset
benchmarking is another important line of action that can facilitate research to improve the
models’ ef cacy.
7.2 Exposure of COVID-19 Patients to Other Disease
An appropriate policy can be formulated based on the  ndings of the approaches that
illustrate the exposure of COVID-19 patients to other diseases such as hypertension, sleep
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disturbances, suicidal thoughts, and similar problems. Current surveys and questionnaire-based
studies are not well structured and lack the involvement of an appropriate population sample size.
Well-integrated surveys incorporating demographic, socioeconomic, and health variables should
be performed involving both civilians and medical professionals to unravel the psychological and
physiological ailments.
Figure 2: The future research directions in COVID-19 diagnostic & prognosis models
7.3 Preexisting Medical Conditions and COVID-19
Analysis of COVID-19 data to study the inuence of preexisting diseases such as CVD,
diabetes, and lung diseases is mainly based on the data from one or two countries and is not
generalized. Predominantly, retrospective studies are conducted, which necessitates prospective
studies from multi-country data. A dataset comprising symptomatic as well as asymptomatic
patients is urgently required.
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7.4 Disparity of COVID-19 Cases for Various Genders
Studies that analyze gender-based vulnerabilty utilize the data of hospitalized patients where
most are in a severe condition. The data for non-hospitalized patients, both self-quarantined,
and with mild symptoms is desirable to explore the function of gender in combating COVID-19.
Analysis should be done with the dataset adjusted for ethnicity, country, and age groups.
7.5 Role of Age Group to Combat COVID-19
Innovative complex models that can incorporate fatalities over a longer period are needed.
The results from models trained on short-term death data are overrated and exaggerated. Data
containing information of patients in hospital and quarantined, both symptomatic infectious and
asymptomatic infectious is necessary to determine the relationship between various age groups
and their vulnerability to severe illness and mortality for COVID-19.
7.6 Prediction of Mortality and Severity of COVID-19
Diversi ed data are required for integrating personal information, living conditions, health
systems, and demographic information to make appropriate predictions. Metrics such as CFR
and IFR alone can be misleading to represent the mortality of COVID-19 [114,115]. Additional
metrics such as symptomatic CFR, asymptomatic CFR, and IFR should be used. Using a dataset
adjusted for age group, demographics, and co morbidity can portray people’s general outcomes.
7.7 Impact of Adjusted Datasets on Prediction Models
Predominantly, the prediction models that currently are used either apply smaller datasets
from single/multiple countries or the datasets are not adjusted to accommodate asymptomatic and
self-quarantined individuals. This may result in the overstatement and exaggeration of infection
and fatality rates. Adjusted datasets are essential to present balanced and more realistic CFR and
IFR results.
8 Conclusion
Pandemics pose a huge threat to human existence as they spread worldwide, impacting
physical and mental health. Apart from many deaths, widespread, long-term consequences inu-
ence national and international health policies and contingency plans. With the rapid spread of
COVID-19, the general public and, particularly, governments face the challenging task of coping
with many patients, ensuring medical and food supplies, and investigating the probable causes
of the outbreak. Many medical researchers, data analysts, and biotechnologists have initiated
research focusing on  nding solutions for robust diagnosis, prediction of the approximate number
of patients in cities and countries, and factors that may have a positive or negative impact on the
spread and recovery from COVID-19. The current study groups such works under nine categories
for age, gender, the outcome of the disease, method used for prediction, and role of underlying
medical conditions. However, the emphasis is on models that predict mortality or the severity of
COVID-19 in patients, the role of age and sex, impact of preexisting medical conditions, and
exposure of COVID-19 patients to other diseases because the studies that resort under other
groups have previously been discussed in several review papers.
The prediction models largely use simple datasets without adjusting for age group, comorbidi-
ties, and demographic information, which would produce different results if such parameters were
incorporated. Complex models capable of integrating such parameters are required to provide
ef cient and reliable predictions. Approaches that consider government policies regarding the
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prevention of COVID-19, social distancing, self-seclusion, and quarantine are not accommodated
in these models, which substantially reduces their ef cacy. Conversely, datasets used for predictive
and analytical models are gathered from hospitals and exclude patients with mild symptoms
or who are asymptomatic. Therefore, the results can be somewhat overstated and exaggerated.
Predominantly, the data are not adjusted for ethnicity, gender, age group, and preexisting medical
complications, which is critical for analysis as the infection and case fatality rates vary by location
and from nation to nation. CFR and IFR are most widely used to estimate the probability of
severe illness and mortality, which, when used alone, can be misleading indicators to represent
COVID-19 mortality. In summary, complex models with multiple parameters and diversi ed
datasets containing detailed information of patients (such as demographic, personal, and health
information) should be focused on in future investigations.
Finally, despite the critiques and de ciencies of the studies discussed herein, psychological and
physiological analyses performed in such studies unravel many important factors and indicators to
understand their impact and role in dealing with the widely spread COVID-19. Medical conditions
that aggravate illness help medical experts to plan appropriately to cope ef ciently with the
inux of patients. Conversely, psychological problems found among COVID-19 patients of various
communities are indicators that can help other communities de ne remedial policies in advance.
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